Optimizing Clinical Implementation of Hypofractionation: Comprehensive Evidence Synthesis and Practical Guidelines for Low- and Middle-Income Settings

Maria Thereza Mansur Starling,Stephane Thibodeau,Cecília Félix Penido Mendes de Sousa,Felipe Cicci Farinha Restini,Gustavo A. Viani,Andre G. Gouveia,Lucas C. Mendez,Gustavo Nader Marta,Fabio Ynoe Moraes

DOI: https://doi.org/10.3390/cancers16030539

2024-01-27

Cancers

Abstract:The global cancer burden, especially in low- and middle-income countries (LMICs), worsens existing disparities, amplified by the rising costs of advanced treatments. The shortage of radiation therapy (RT) services is a significant issue in LMICs. Extended conventional treatment regimens pose significant challenges, especially in resource-limited settings. Hypofractionated radiotherapy (HRT) and ultra-hypofractionated/stereotactic body radiation therapy (SBRT) offer promising alternatives by shortening treatment durations. This approach optimizes the utilization of radiotherapy machines, making them more effective in meeting the growing demand for cancer care. Adopting HRT/SBRT holds significant potential, especially in LMICs. This review provides the latest clinical evidence and guideline recommendations for the application of HRT/SBRT in the treatment of breast, prostate, and lung cancers. It emphasizes the critical importance of rigorous training, technology, stringent quality assurance, and safety protocols to ensure precise and secure treatments. Additionally, it addresses practical considerations for implementing these treatments in LMICs, highlighting the need for comprehensive support and collaboration to enhance patient access to advanced cancer care.

oncology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the challenges faced by low - and middle - income countries (LMICs) in cancer treatment, especially the insufficiency of these countries in accessing advanced radiotherapy services. Specifically, the paper explores how to optimize clinical implementation through the use of hypofractionated radiotherapy (HRT) and ultra - hypofractionated / stereotactic body radiation therapy (SBRT) to shorten the treatment time and improve the utilization efficiency of radiotherapy equipment, so as to better meet the growing cancer treatment needs in these regions. The paper provides the latest clinical evidence and application guidelines, with special emphasis on the importance of strict training, advanced technology and strict safety protocols required for the implementation of these technologies in resource - limited environments.

### Main problem summary:
1. **Increasing global cancer burden**: Especially in low - and middle - income countries, cancer cases and deaths account for the majority in the world, but the coverage rate of cancer registration systems in these countries is low, which affects the accurate assessment and planning of local epidemiology.
2. **Shortage of radiotherapy services**: Globally, especially in low - and middle - income countries, radiotherapy equipment and services are severely insufficient. High - income countries have one radiotherapy device per 120,000 people, while low - income countries have one per 5 million people.
3. **Limitations of traditional radiotherapy regimens**: Traditional long - course radiotherapy regimens are difficult to implement in resource - limited environments and require shorter treatment cycles and higher equipment utilization.
4. **Advantages of HRT and SBRT**: Hypofractionated radiotherapy and ultra - hypofractionated / stereotactic body radiation therapy can significantly shorten the treatment time, improve the utilization efficiency of radiotherapy equipment, while maintaining or improving the treatment effect and reducing side effects.
5. **Challenges in implementing HRT and SBRT**: Although HRT and SBRT have obvious advantages, the implementation of these technologies in low - and middle - income countries still faces challenges in terms of technology, infrastructure and personnel training.

Through systematic review and analysis of clinical evidence, the paper aims to provide practical guidance for low - and middle - income countries to help them better cope with the challenges of cancer treatment.